Author/Authors :
Himoto, Takashi Department of Integrated Medicine, Japan , Kurokohchi, Kazutaka Kagawa University - School of Medicine - Department of Gastroenterology and Neurology, Japan , Watanabe, Seishiro Kagawa Prefectural Central Hospital - Department of Internal Medicine, Japan , Masaki, Tsutomu Kagawa University - School of Medicine - Department of Gastroenterology and Neurology, Japan
Abstract :
Contexts: Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. Because less than 20% of patients with HCC are resectable, various types of non-surgical treatment have been developed. Evidence Acquisition: At present, radiofrequency ablation (RFA) is accepted as the standard local treatment for patients with HCC because of its superior local control and overall survival compared to other local treatments. Results: New devices for RFA and combination treatments of RFA with other procedures have been developed to improve anti-tumoral effects. Conclusions: This review mainly focuses on the status of RFA in the management of HCC and recent advances in RFA treatment technology.
Keywords :
Carcinoma , Hepatocellular , Treatment , Catheter Ablation
